Literature DB >> 10023869

Impact of prenatal screening on maternity services--Finnish physicians' opinions.

E Hemminki1, P Santalahti, H Toiviainen.   

Abstract

BACKGROUND: The purpose of this survey was to find out whether Finnish physicians had thought about or had observed resource or organizational effects due to the offering of prenatal screening.
METHODS: A mailed questionnaire survey sent in 1996-1997 in Finland to all leading Finnish obstetrician-gynecologists, to a random sample of obstetrician-gynecologists providing prenatal care, to general practitioners providing maternity care, and to other general practitioners. The number of respondents was 322 (response rate 70%).
RESULTS: Most physicians supported the screening programs currently in wide use in Finland (serum screening for Down's syndrome and ultrasound for malformations), and over a third wanted to introduce the two genetic carrier screenings asked about. Most thought Down's screening took up resources, but they did not consider this to be important. The impact of screening on public or customer images of prenatal care was not an important issue. Instead, a diversity of opinions was expressed on whether the increasing numbers of prenatal screenings require organizational changes in current prenatal care provided within primary care, or whether a shift to hospital clinics is necessary to achieve more specialized care.
CONCLUSIONS: Most physicians were not concerned by the potential organizational and resource implications of prenatal screening, and apparently they judge screening more from a health and individual patient point of view.

Entities:  

Mesh:

Year:  1999        PMID: 10023869

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  1 in total

1.  Exploring general practitioners' experience of informing women about prenatal screening tests for foetal abnormalities: a qualitative focus group study.

Authors:  Cate Nagle; Sharon Lewis; Bettina Meiser; Jane Gunn; Jane Halliday; Robin Bell
Journal:  BMC Health Serv Res       Date:  2008-05-28       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.